CY1116323T1 - ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ TNFα-ΣΧΕΤΙΖΟΜΕΝΩΝ ΔΙΑΤΑΡΑΧΩΝ - Google Patents

ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ TNFα-ΣΧΕΤΙΖΟΜΕΝΩΝ ΔΙΑΤΑΡΑΧΩΝ

Info

Publication number
CY1116323T1
CY1116323T1 CY20151100471T CY151100471T CY1116323T1 CY 1116323 T1 CY1116323 T1 CY 1116323T1 CY 20151100471 T CY20151100471 T CY 20151100471T CY 151100471 T CY151100471 T CY 151100471T CY 1116323 T1 CY1116323 T1 CY 1116323T1
Authority
CY
Cyprus
Prior art keywords
tnfα
disorders treatment
treated disorders
treated
treatment
Prior art date
Application number
CY20151100471T
Other languages
English (en)
Inventor
Subhashis Banerjee
Lori K Taylor
Clive E Spiegler
Daniel Edward Tracey
Eliot Keith Chartash
Rebecca S Hoffman
William T Barchuk
Philip Yan
Anwar Murtaza
Jochen G Salfeld
Steven Fischkoff
Original Assignee
Abbvie Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07150442.7A external-priority patent/EP1944322B1/en
Application filed by Abbvie Biotechnology Ltd filed Critical Abbvie Biotechnology Ltd
Publication of CY1116323T1 publication Critical patent/CY1116323T1/el

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Περιγράφονται μέθοδοι θεραπευτικής αγωγής ΤΝFα-σχετιζόμενων διαταραχών που περιλαμβάνουν χορήγηση αναστολέων TNFα, συμπεριλαμβανομένων αντισωμάτων TNFα.
CY20151100471T 2002-07-19 2015-05-28 ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ TNFα-ΣΧΕΤΙΖΟΜΕΝΩΝ ΔΙΑΤΑΡΑΧΩΝ CY1116323T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39727502A 2002-07-19 2002-07-19
US41108102A 2002-09-16 2002-09-16
US41749002A 2002-10-10 2002-10-10
US45577703A 2003-03-18 2003-03-18
EP07150442.7A EP1944322B1 (en) 2002-07-19 2003-07-18 Treatment of TNF alpha related disorders

Publications (1)

Publication Number Publication Date
CY1116323T1 true CY1116323T1 (el) 2017-02-08

Family

ID=58457928

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100471T CY1116323T1 (el) 2002-07-19 2015-05-28 ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ TNFα-ΣΧΕΤΙΖΟΜΕΝΩΝ ΔΙΑΤΑΡΑΧΩΝ

Country Status (1)

Country Link
CY (1) CY1116323T1 (el)

Similar Documents

Publication Publication Date Title
MX342777B (es) Inhibidores tnfa para usarse en el tratamiento de trastornos relacionados con tnfa.
NL301145I2 (nl) Tirbanibulin
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
NO20060030L (no) Kombinasjonsterapi for b-cellelidelser
NO20045043L (no) Pyrimidinonforbindelser, sammensetninger og fremgangsmater
SE0203752D0 (sv) New compounds
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
SG148217A1 (en) Method for treating adamts-5-associated disease
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
EA200400235A1 (ru) Комбинированная терапия для лечения рака
NL1025873A1 (nl) Doseringsvormen en wijzen van behandeling met vegfr-remmers.
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
TW200508233A (en) Chk-1 inhibitors
ATE423110T1 (de) Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
NO20053071L (no) Kalsilytiske forbindelser.
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
DE60214019D1 (de) Stickstoff enthaltende heterozyklen und ihre verwendung als raf inhibitoren
CY1116323T1 (el) ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ TNFα-ΣΧΕΤΙΖΟΜΕΝΩΝ ΔΙΑΤΑΡΑΧΩΝ